- RBC Capital analyst Douglas Miehm raised the price target for Dialogue Health Technologies Inc CARE to C$10 from C$9 with the Sector Perform rating on the shares.
- Last week CARE announced the acquisition of London, U.K.-based Tictrac Ltd. for up to C$56 million (5.3x 2022E revenues). Tictrac is a SaaS-based provider of a global health and wellness platform that enables healthier living for everyone.
- Miehm views the Tictrac acquisition positively, as it strengthens Dialogue’s value proposition as a fully integrated digital health platform.
- Price Action: CARE shares are trading higher by 1.52% at C$6.00 on TSX on the last check Monday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
